RT Journal Article
SR Electronic
T1 Evaluation of clinical characteristics of Legionella pneumophila pneumonia diagnosed by metagenomic Next-Generation Sequencing:A Retrospective Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.31.24316546
DO 10.1101/2024.10.31.24316546
A1 He, Zhixiong
A1 Chu, Ruixiang
A1 Ke, Junyi
A1 Li, Qinglan
A1 Wu, Qi
A1 Sheng, Jiao
A1 Liu, Ping
A1 Duan, Minchao
YR 2024
UL http://medrxiv.org/content/early/2024/11/04/2024.10.31.24316546.abstract
AB Purpose This study aimed to summarize the clinical characteristics and outcomes of Legionella pneumophila (L. pneumophila) pneumonia to assist clinicians in accurately and early identifying this disease. The findings provide evidence to guide decision-making for L. pneumophila infection and improve treatment success rates.Patients and methods A retrospective analysis of clinical data was conducted on 19 patients diagnosed with L. pneumophila infection at our hospital using Metagenomic next-generation sequencing (mNGS).Results The study included 16 male and 3 female participants, with an average age of 59.5±16.2 years. The majority of participants were immunocompromised (13/19). The most common symptoms included fever (n=11) with a median peak value of 39.5°C, cough (n = 15), expectoration (n = 14), dyspnea (n = 10), poor appetite (n = 9), fatigue (n = 8), and headache (n = 3). Elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were observed in all patients, while procalcitonin (PCT) and lactate dehydrogenase (LDH) levels were significantly higher in the severe group compared to the non-severe group. Lymphocyte count levels were also significantly lower in the severe group (P<0.05). Common CT manifestations included flake high-density shadows (n = 17), pleural effusion (n = 11), consolidation (n = 4), ground-glass exudation (n = 4), and bronchial inflation signs (n = 3). The most prevalent underlying diseases were hypertension (n = 9), diabetes (n = 8), AIDS (n = 6), COPD (n = 5), and malignancies (n = 3). Common complications included acute liver injury (n=7), acute respiratory failure (n=6), electrolyte disorders (n=5), sepsis (n=3), MODS (n=2), and ARDS (n=1). The majority of patients received treatment with quinolones (16/19), with six patients requiring mechanical ventilation therapy. Tragically, 2 patients in the severe pneumonia group succumbed to sepsis and multiple organ failure.Conclusion L. pneumophila pneumonia is an acute respiratory infection. If not promptly diagnosed, patients may develop severe pneumonia, multiorgan failure, or face fatal outcomes. mNGS can be used for rapid and accurate diagnosis of L. pneumophila infections, thereby improving treatment outcomes. Early initiation of quinolones or combination therapy with other medications has demonstrated a significant therapeutic benefit for patients with L. pneumophila pneumonia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee of The Affiliated Changsha Hospital of XiangyaSchool of Medicine (Grant number: 2024 (11) V. 1.0).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data analysed during the current study are available in the Harvard Dataverse (https://doi.org/10.7910/DVN/SFXXBM).Compliance with ethical standardsThis study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of The Affiliated Changsha Hospital of XiangyaSchool of Medicine (Grant number: 2024 (11) V. 1.0). The authors were unable to obtain information that could identify individual participants during or after data collection. The Institutional Review Board (IRB) of The First Hospital of Changsha reviewed and approved our research topic in accordance with the ‘Ethical Review Methods for Life Sciences and Medical Research Involving Humans’ (National Health Science and Education Development [2023] No. 4).L. pneumophilaLegionella pneumophilamNGSmetagenomic next-generation sequencingCAPcommunity-acquired pneumoniaBALFbronchoalveolar lavage fluidNEneutrophilLYlymphocyteCKcreatine kinaseCRPC-reactive proteinESRerythrocyte sedimentation ratePCTprocalcitoninARDSacute respiratory distress syndromeMODSmultiple organ failure syndrome